BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
BioCaptiva has raised $2.1M in total funding. The most recent round was Series Unknown. The last funding was announced in March 2026.
BioCaptiva's investors include Scottish Enterprise, University of Edinburgh, Archangels, Cancer Research Horizons, Old College Capital.
BioCaptiva is headquartered in Edinburgh, United Kingdom.
BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
BioCaptiva is at the Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioCaptiva — Funding & Investors." VCBacked, March 9, 2026, https://www.vcbacked.co/company/biocaptiva. Accessed August 6, 2026.
VCBacked. (2026). BioCaptiva — Funding & Investors. Retrieved August 6, 2026, from https://www.vcbacked.co/company/biocaptiva
{{cite web |title=BioCaptiva — Funding & Investors |url=https://www.vcbacked.co/company/biocaptiva |website=VCBacked |access-date=August 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated